BACKGROUND: Atrial fibrillation (AF) is an independent risk factor for stroke and a significant predictor of mortality. Evidence-based guidelines for stroke prevention in AF recommend antithrombotic therapy corresponding to the risk of stroke. In practice, many patients with AF do not receive the appropriate antithrombotic therapy and are left either unprotected or inadequately protected against stroke. The purpose of the Global Anticoagulant Registry in the FIELD (GARFIELD) is to determine ...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Publisher copy:
- Copyright holder:
- Apenteng et al.
- Copyright date:
- © 2013 Apenteng et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.
If you are the owner of this record, you can report an update to it here: Report update to this record